AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas

Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach

(2015) Malcolm H. Squires et al.   ANNALS OF SURGICAL ONCOLOGY

The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors

(2015) Mauro Cives et al.   DRUGS

Sequencing and Combining Systemic Therapies for Pancreatic Neuroendocrine Tumors

(2015) Matthew H. Kulke   JOURNAL OF CLINICAL ONCOLOGY

Carcinoid and Neuroendocrine Tumors: Building on Success

(2015) Pamela L. Kunz   JOURNAL OF CLINICAL ONCOLOGY

In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model

(2014) Min-Hui Cui et al.   MAGNETIC RESONANCE IN MEDICINE

Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors

(2013) Pamela L. Kunz et al.   PANCREAS

Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity

(2012) Z Yuan et al.   CANCER GENE THERAPY

Clathrin-mediated Endocytosis and Subsequent Endo-Lysosomal Trafficking of Adeno-associated Virus/Phage

(2012) Charlotte A. Stoneham et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model

(2012) Thomas J. Quinn et al.   SURGERY

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

(2011) Y. Jiao et al.   SCIENCE

Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma

(2010) Fernanda I. Staquicini et al.   JOURNAL OF CLINICAL INVESTIGATION

NANETS Treatment Guidelines

(2010) Matthew H. Kulke et al.   PANCREAS

Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via Pdx1-Directed Inactivation of Men1

(2009) H.-C. J. Shen et al.   CANCER RESEARCH

A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer

(2009) M. Trepel et al.   MOLECULAR CANCER THERAPEUTICS

Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature

(2009) Melissa C. Paoloni et al.   PLoS One

Tumor vasculature-targeted delivery of tumor necrosis factor-α*

(2008) Anita Tandle et al.   CANCER

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY

A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging

(2008) A. Hajitou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Medical Management of Pancreatic Neuroendocrine Tumors

(2007) Thierry Delaunoit et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY